Skip to main content
Premium Trial:

Request an Annual Quote

Cancer Genetics Inks Coverage Agreement With Illinois Blue Cross Blue Shield

NEW YORK (GenomeWeb) – Cancer Genetics today announced it has arranged an in-network provider agreement with Blue Cross Blue Shield of Illinois to offer cancer diagnostic services.

Under the terms of the agreement, BCBS Illinois' network will have access to Cancer Genetics' full range of oncology-focused tests. The insurance plan covers 7.3 million people in the state.

Financial details were not disclosed.

BCBS Illinois is part of Health Care Service Corporation, the fourth largest insurer in the country, which also includes BCBS networks in Texas, New Mexico, Oklahoma, and Montana.

The Rutherford, New Jersey-based firm said in a statement that establishing relationships with leading payers is part of its reimbursement strategy. In April, Cancer Genetics signed a deal with America's Choice Provider Network to provide its cancer diagnostic services. In July, the firm signed a similar deal with Harvard Pilgrim Healthcare.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.